(+)-catechin multiple interactions ISO RGD:1318426 6480464 [Catechin co-treated with Grape Seed Proanthocyanidins] results in decreased expression of FLRT2 mRNA CTD PMID:24763279 (-)-epigallocatechin 3-gallate multiple interactions ISO RGD:1318426 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of FLRT2 mRNA CTD PMID:22079256 (S)-nicotine increases expression ISO RGD:1318426 6480464 Nicotine results in increased expression of FLRT2 mRNA CTD PMID:23825647 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of FLRT2 mRNA CTD PMID:29097150 17beta-estradiol multiple interactions ISO RGD:1318426 6480464 [Estradiol co-treated with TGFB1 protein] results in increased expression of FLRT2 mRNA, [Progesterone co-treated with Estradiol] results in decreased expression of FLRT2 mRNA CTD PMID:17404688 , PMID:30165855 17beta-estradiol multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of FLRT2 mRNA CTD PMID:32741896 17beta-estradiol affects expression ISO RGD:1318426 6480464 Estradiol affects the expression of FLRT2 mRNA CTD PMID:14699072 17beta-estradiol 3-benzoate multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of FLRT2 mRNA CTD PMID:32741896 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1620405 6480464 Tetrachlorodibenzodioxin affects the expression of FLRT2 mRNA CTD PMID:26377647 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of FLRT2 mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of FLRT2 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of FLRT2 mRNA CTD PMID:32109520 2,3,7,8-Tetrachlorodibenzofuran decreases expression EXP 6480464 2 more ... CTD PMID:32109520 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1318426 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of FLRT2 mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of FLRT2 mRNA CTD PMID:28628672 4,4'-sulfonyldiphenol multiple interactions ISO RGD:1318426 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of FLRT2 mRNA CTD PMID:28628672 4,4'-sulfonyldiphenol increases methylation ISO RGD:1620405 6480464 bis(4-hydroxyphenyl)sulfone results in increased methylation of FLRT2 promoter CTD PMID:33297965 4,4'-sulfonyldiphenol increases expression ISO RGD:1620405 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of FLRT2 mRNA CTD PMID:30951980 4-hydroxyphenyl retinamide decreases expression ISO RGD:1620405 6480464 Fenretinide results in decreased expression of FLRT2 mRNA CTD PMID:28973697 5-fluorouracil affects response to substance ISO RGD:1318426 6480464 FLRT2 protein affects the susceptibility to Fluorouracil CTD PMID:16217747 aflatoxin B1 decreases methylation ISO RGD:1318426 6480464 Aflatoxin B1 results in decreased methylation of FLRT2 exon, Aflatoxin B1 results in decreased methylation of FLRT2 gene CTD PMID:27153756 , PMID:30157460 aflatoxin B1 increases expression ISO RGD:1318426 6480464 Aflatoxin B1 results in increased expression of FLRT2 mRNA CTD PMID:27153756 , PMID:32234424 Aflatoxin B2 alpha increases methylation ISO RGD:1318426 6480464 aflatoxin B2 results in increased methylation of FLRT2 exon CTD PMID:30157460 antirheumatic drug increases expression ISO RGD:1318426 6480464 Antirheumatic Agents results in increased expression of FLRT2 mRNA CTD PMID:24449571 arsenite(3-) decreases expression ISO RGD:1318426 6480464 arsenite results in decreased expression of FLRT2 mRNA CTD PMID:23974009 atrazine affects methylation EXP 6480464 Atrazine affects the methylation of FLRT2 gene CTD PMID:28931070 benzo[a]pyrene decreases expression ISO RGD:1318426 6480464 Benzo(a)pyrene results in decreased expression of FLRT2 mRNA CTD PMID:20064835 benzo[a]pyrene increases expression ISO RGD:1318426 6480464 Benzo(a)pyrene results in increased expression of FLRT2 mRNA CTD PMID:32234424 benzo[a]pyrene decreases methylation ISO RGD:1318426 6480464 Benzo(a)pyrene results in decreased methylation of FLRT2 exon CTD PMID:27901495 benzo[a]pyrene increases expression ISO RGD:1620405 6480464 Benzo(a)pyrene results in increased expression of FLRT2 mRNA CTD PMID:32417428 benzo[a]pyrene affects methylation ISO RGD:1318426 6480464 Benzo(a)pyrene affects the methylation of FLRT2 5' UTR CTD PMID:27901495 Benzo[k]fluoranthene decreases expression ISO RGD:1620405 6480464 benzo(k)fluoranthene results in decreased expression of FLRT2 mRNA CTD PMID:26377693 bis(2-ethylhexyl) phthalate increases expression ISO RGD:1620405 6480464 Diethylhexyl Phthalate results in increased expression of FLRT2 mRNA CTD PMID:28085963 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of FLRT2 mRNA CTD PMID:29097150 more ... bisphenol A affects methylation ISO RGD:1318426 6480464 bisphenol A affects the methylation of FLRT2 gene CTD PMID:31601247 bisphenol A increases expression ISO RGD:1318426 6480464 bisphenol A results in increased expression of FLRT2 mRNA CTD PMID:29275510 bisphenol A increases expression ISO RGD:1620405 6480464 bisphenol A results in increased expression of FLRT2 mRNA CTD PMID:30951980 bisphenol A multiple interactions ISO RGD:1318426 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of FLRT2 gene, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of FLRT2 mRNA CTD PMID:28628672 , PMID:31601247 bisphenol F increases expression ISO RGD:1620405 6480464 bisphenol F results in increased expression of FLRT2 mRNA CTD PMID:30951980 carbamazepine affects expression ISO RGD:1318426 6480464 Carbamazepine affects the expression of FLRT2 mRNA CTD PMID:25979313 CGP 52608 multiple interactions ISO RGD:1318426 6480464 CGP 52608 promotes the reaction [RORA protein binds to FLRT2 gene] CTD PMID:28238834 choline multiple interactions ISO RGD:1620405 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of FLRT2 gene CTD PMID:20938992 cis-caffeic acid multiple interactions ISO RGD:1318426 6480464 caffeic acid promotes the reaction [Thapsigargin results in decreased expression of FLRT2 mRNA] CTD PMID:19442820 cisplatin multiple interactions ISO RGD:1318426 6480464 [Cisplatin co-treated with jinfukang] results in decreased expression of FLRT2 mRNA CTD PMID:27392435 clobetasol decreases expression ISO RGD:1620405 6480464 Clobetasol results in decreased expression of FLRT2 mRNA CTD PMID:27462272 crocidolite asbestos decreases expression ISO RGD:1318426 6480464 Asbestos, Crocidolite results in decreased expression of FLRT2 mRNA CTD PMID:29523930 cyclosporin A decreases expression ISO RGD:1318426 6480464 Cyclosporine results in decreased expression of FLRT2 mRNA CTD PMID:27989131 cytarabine decreases expression ISO RGD:1318426 6480464 Cytarabine results in decreased expression of FLRT2 mRNA CTD PMID:21198554 dexamethasone multiple interactions ISO RGD:1318426 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of FLRT2 mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of FLRT2 mRNA CTD PMID:28628672 dorsomorphin multiple interactions ISO RGD:1318426 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 entinostat multiple interactions ISO RGD:1318426 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FLRT2 mRNA CTD PMID:27188386 entinostat decreases expression ISO RGD:1318426 6480464 entinostat results in decreased expression of FLRT2 mRNA CTD PMID:26272509 epoxiconazole increases expression ISO RGD:1620405 6480464 epoxiconazole results in increased expression of FLRT2 mRNA CTD PMID:35436446 folic acid multiple interactions ISO RGD:1620405 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of FLRT2 gene CTD PMID:20938992 folic acid decreases expression ISO RGD:1620405 6480464 Folic Acid results in decreased expression of FLRT2 mRNA CTD PMID:25629700 fonofos increases methylation ISO RGD:1318426 6480464 Fonofos results in increased methylation of FLRT2 promoter CTD PMID:22847954 formaldehyde increases expression ISO RGD:1318426 6480464 Formaldehyde results in increased expression of FLRT2 mRNA CTD PMID:27664576 fulvestrant multiple interactions ISO RGD:1318426 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of FLRT2 gene CTD PMID:31601247 furan increases expression EXP 6480464 furan results in increased expression of FLRT2 mRNA CTD PMID:27387713 furan decreases methylation EXP 6480464 furan results in decreased methylation of FLRT2 gene CTD PMID:27387713 indometacin multiple interactions ISO RGD:1318426 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of FLRT2 mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of FLRT2 mRNA CTD PMID:28628672 L-methionine multiple interactions ISO RGD:1620405 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of FLRT2 gene CTD PMID:20938992 maneb multiple interactions ISO RGD:1620405 6480464 [Maneb co-treated with Paraquat] results in decreased expression of FLRT2 mRNA CTD PMID:36117858 manganese(II) chloride increases expression EXP 6480464 manganese chloride results in increased expression of FLRT2 mRNA CTD PMID:28801915 methotrexate affects response to substance ISO RGD:1318426 6480464 FLRT2 protein affects the susceptibility to Methotrexate CTD PMID:16217747 methylmercury chloride decreases expression ISO RGD:1318426 6480464 methylmercuric chloride results in decreased expression of FLRT2 mRNA CTD PMID:28001369 mifepristone decreases expression ISO RGD:1318426 6480464 Mifepristone results in decreased expression of FLRT2 mRNA CTD PMID:17584828 N-methyl-4-phenylpyridinium decreases expression ISO RGD:1318426 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of FLRT2 mRNA CTD PMID:24810058 N-Nitrosopyrrolidine increases expression ISO RGD:1318426 6480464 N-Nitrosopyrrolidine results in increased expression of FLRT2 mRNA CTD PMID:32234424 nickel dichloride increases expression ISO RGD:1318426 6480464 nickel chloride results in increased expression of FLRT2 mRNA CTD PMID:17312168 nicotine increases expression ISO RGD:1318426 6480464 Nicotine results in increased expression of FLRT2 mRNA CTD PMID:23825647 O-methyleugenol increases expression ISO RGD:1318426 6480464 methyleugenol results in increased expression of FLRT2 mRNA CTD PMID:32234424 ozone multiple interactions ISO RGD:1620405 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of FLRT2 mRNA, [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of FLRT2 mRNA CTD PMID:34911549 panobinostat multiple interactions ISO RGD:1318426 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FLRT2 mRNA CTD PMID:27188386 panobinostat decreases expression ISO RGD:1318426 6480464 panobinostat results in decreased expression of FLRT2 mRNA CTD PMID:26272509 paracetamol affects expression ISO RGD:1620405 6480464 Acetaminophen affects the expression of FLRT2 mRNA CTD PMID:17562736 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of FLRT2 mRNA CTD PMID:33387578 paracetamol increases expression ISO RGD:1318426 6480464 Acetaminophen results in increased expression of FLRT2 mRNA CTD PMID:29067470 paraquat increases expression EXP 6480464 Paraquat results in increased expression of FLRT2 mRNA CTD PMID:32680482 paraquat multiple interactions ISO RGD:1620405 6480464 [Maneb co-treated with Paraquat] results in decreased expression of FLRT2 mRNA CTD PMID:36117858 parathion increases methylation ISO RGD:1318426 6480464 Parathion results in increased methylation of FLRT2 promoter CTD PMID:22847954 phenylmercury acetate increases expression ISO RGD:1318426 6480464 Phenylmercuric Acetate results in increased expression of FLRT2 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:1318426 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FLRT2 mRNA CTD PMID:27188386 phenytoin increases expression ISO RGD:1318426 6480464 Phenytoin results in increased expression of FLRT2 mRNA CTD PMID:14741686 potassium chromate multiple interactions ISO RGD:1318426 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of FLRT2 mRNA CTD PMID:22079256 potassium chromate decreases expression ISO RGD:1318426 6480464 potassium chromate(VI) results in decreased expression of FLRT2 mRNA CTD PMID:22079256 potassium dichromate increases expression ISO RGD:1620405 6480464 Potassium Dichromate results in increased expression of FLRT2 mRNA CTD PMID:23608068 progesterone multiple interactions ISO RGD:1318426 6480464 [Progesterone co-treated with Estradiol] results in decreased expression of FLRT2 mRNA CTD PMID:17404688 resveratrol multiple interactions ISO RGD:1318426 6480464 [Plant Extracts co-treated with Resveratrol] results in decreased expression of FLRT2 mRNA CTD PMID:23557933 rotenone decreases expression ISO RGD:1318426 6480464 Rotenone results in decreased expression of FLRT2 mRNA CTD PMID:29955902 SB 431542 multiple interactions ISO RGD:1318426 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 silicon dioxide decreases expression ISO RGD:1318426 6480464 Silicon Dioxide analog results in decreased expression of FLRT2 mRNA CTD PMID:25895662 silver atom decreases expression ISO RGD:1620405 6480464 Silver results in decreased expression of FLRT2 mRNA CTD PMID:27131904 silver(0) decreases expression ISO RGD:1620405 6480464 Silver results in decreased expression of FLRT2 mRNA CTD PMID:27131904 terbufos increases methylation ISO RGD:1318426 6480464 terbufos results in increased methylation of FLRT2 promoter CTD PMID:22847954 testosterone multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of FLRT2 mRNA CTD PMID:32741896 testosterone enanthate affects expression ISO RGD:1318426 6480464 testosterone enanthate affects the expression of FLRT2 mRNA CTD PMID:17440010 thapsigargin decreases expression ISO RGD:1318426 6480464 Thapsigargin results in decreased expression of FLRT2 mRNA CTD PMID:19442820 thapsigargin multiple interactions ISO RGD:1318426 6480464 4-methoxycinnamate methyl ester promotes the reaction [Thapsigargin results in decreased expression of FLRT2 mRNA] more ... CTD PMID:19442820 titanium dioxide increases expression ISO RGD:1318426 6480464 titanium dioxide results in increased expression of FLRT2 mRNA CTD PMID:19695317 titanium dioxide decreases expression EXP 6480464 titanium dioxide results in decreased expression of FLRT2 mRNA CTD PMID:30012374 titanium dioxide decreases expression ISO RGD:1620405 6480464 titanium dioxide results in decreased expression of FLRT2 mRNA CTD PMID:23557971 torcetrapib increases expression ISO RGD:1318426 6480464 torcetrapib results in increased expression of FLRT2 mRNA CTD PMID:23228038 trans-caffeic acid multiple interactions ISO RGD:1318426 6480464 caffeic acid promotes the reaction [Thapsigargin results in decreased expression of FLRT2 mRNA] CTD PMID:19442820 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of FLRT2 mRNA CTD PMID:33387578 trichostatin A increases expression ISO RGD:1318426 6480464 trichostatin A results in increased expression of FLRT2 mRNA CTD PMID:24935251 trichostatin A multiple interactions ISO RGD:1318426 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FLRT2 mRNA CTD PMID:27188386 trichostatin A decreases expression ISO RGD:1318426 6480464 trichostatin A results in decreased expression of FLRT2 mRNA CTD PMID:24935251 , PMID:26272509 trovafloxacin increases expression ISO RGD:1620405 6480464 trovafloxacin results in increased expression of FLRT2 mRNA CTD PMID:35537566 urethane decreases expression ISO RGD:1318426 6480464 Urethane results in decreased expression of FLRT2 mRNA CTD PMID:28818685 valproic acid decreases methylation ISO RGD:1318426 6480464 Valproic Acid results in decreased methylation of FLRT2 gene CTD PMID:29154799 valproic acid increases expression ISO RGD:1318426 6480464 Valproic Acid results in increased expression of FLRT2 mRNA CTD PMID:24935251 valproic acid multiple interactions ISO RGD:1318426 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FLRT2 mRNA CTD PMID:27188386 valproic acid decreases expression ISO RGD:1318426 6480464 Valproic Acid results in decreased expression of FLRT2 mRNA CTD PMID:23179753 more ...